MedTrace Logo

Study of the Cabochon System for Improvement in the Appearance of Cellulite

NCT01671839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2019-12-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and effectiveness of the Cabochon System for the improvement in the appearance of cellulite.

Conditions

  • Gynoid Lipodystrophy

Interventions

DEVICE

Subcutaneous tissue release with the Cabochon System

Device: Subcutaneous tissue release

Sponsors & Collaborators

  • Ulthera, Inc

    collaborator INDUSTRY

  • Merz North America, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael S Kaminer · Skin Care Physicians

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-09-30
Completion
2015-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01671839 on ClinicalTrials.gov